{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T07:51:36Z","timestamp":1759564296507},"reference-count":17,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,9,15]]},"DOI":"10.2169\/internalmedicine.4714-20","type":"journal-article","created":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T22:04:50Z","timestamp":1592172290000},"page":"2297-2300","source":"Crossref","is-referenced-by-count":3,"title":["Dasatinib-induced Nonspecific Interstitial Pneumonia That Developed 7 Years after the Initiation of Dasatinib"],"prefix":"10.2169","volume":"59","author":[{"given":"Daisuke","family":"Takekoshi","sequence":"first","affiliation":[{"name":"Division of Respiratory Medicine, Department of Internal Medicine, Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuma","family":"Matsui","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Department of Internal Medicine, Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Akutsu","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Department of Internal Medicine, Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Nishioka","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Department of Internal Medicine, Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayu","family":"Kiritani","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Department of Internal Medicine, Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keitaro","family":"Okuda","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Department of Internal Medicine, Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Department of Internal Medicine, Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanae","family":"Miyagawa","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Department of Internal Medicine, Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohumi","family":"Utsumi","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Department of Internal Medicine, Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuo","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Department of Internal Medicine, Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Wakui","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Department of Internal Medicine, Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Minagawa","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Department of Internal Medicine, Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Hara","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Department of Internal Medicine, Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Numata","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Department of Internal Medicine, Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Noda","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Department of Surgery, Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rei","family":"Makishima","sequence":"additional","affiliation":[{"name":"Department of Pathology, Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Ikegami","sequence":"additional","affiliation":[{"name":"Department of Pathology, Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Kawabata","sequence":"additional","affiliation":[{"name":"Department of Pathology, Saitama Cardiovascular and Respiratory Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Araya","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Department of Internal Medicine, Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyoshi","family":"Kuwano","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Department of Internal Medicine, Jikei University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Caldemeyer L, Dugan M, Edwards J, Akard L. Long-term side effects of tyrosine kinase inhibitors in chronic myeloid leukemia. Curr Hematol Malig Rep 11: 71-79, 2016.","DOI":"10.1007\/s11899-016-0309-2"},{"key":"2","unstructured":"2. Bergeron A, Rea D, Levy V, et al. Lung abnormalities after dasatinib treatment for chronic myeloid leukemia: a case series. Am J Respir Crit Care Med 176: 814-818, 2007."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Quintas-Cardama A, Kantarjian H, O'Brien S, et al. Pleural effusion in patients with chronic myelogenous leukemia treated with dasatinib after imatinib failure. J Clin Oncol 25: 3908-3914, 2007.","DOI":"10.1200\/JCO.2007.12.0329"},{"key":"4","unstructured":"4. Bristol-Myers Squibb Healthcare i. post-marketing surveillance reports on Sprycel [Internet]. [cited 2019 Sep 9]. Available from: http:\/\/file.bmshealthcare.jp\/sprycel\/pdf\/file\/sp_kaiseki.pdf (in Japanese)."},{"key":"5","unstructured":"5. Ito Y, Tanigawa M, Iwamoto K, et al. Interstitial pneumonitis associated with dasatinib: two case reports and literature review. Respir Investig 57: 506-509, 2019."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Jasielec JK, Larson RA. Dasatinib-related pulmonary toxicity mimicking an atypical infection. J Clin Oncol 34: e46-e48, 2016.","DOI":"10.1200\/JCO.2013.50.1981"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Radaelli F, Bramanti S, Fantini NN, Fabio G, Greco I, Lambertenghi-Deliliers G. Dasatinib-related alveolar pneumonia responsive to corticosteroids. Leuk Lymphoma 47: 1180-1181, 2006.","DOI":"10.1080\/10428190600555868"},{"key":"8","unstructured":"8. Sato M, Watanabe S, Aoki N, et al. [A case of drug-induced organizing pneumonia caused by dasatinib]. Gan To Kagaku Ryoho (Cancer Chemother) 45: 851-854, 2018 (in Japanese, Abstract in English)."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Komada F. [Analysis of time-to-onset of interstitial lung disease after the administration of small molecule molecularly-targeted drugs]. Yakugaku Zasshi (J Pharmacent Soc Japan) 138: 229-235, 2018 (in Japanese, Abstract in English).","DOI":"10.1248\/yakushi.17-00194"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Delomas T, Darne C, Besson C. Lack of recurrence of imatinib-induced interstitial lung disease with nilotinib. Leuk Lymphoma 53: 332-333, 2012.","DOI":"10.3109\/10428194.2011.606940"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Rea D. Management of adverse events associated with tyrosine kinase inhibitors in chronic myeloid leukemia. Ann Hematol 94 Suppl 2: S149-S158, 2015.","DOI":"10.1007\/s00277-015-2318-y"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Deininger MW, Manley P. What do kinase inhibition profiles tell us about tyrosine kinase inhibitors used for the treatment of CML? Leuk Res 36: 253-261, 2012.","DOI":"10.1016\/j.leukres.2011.09.018"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Uitdehaag JC, de Roos JA, van Doornmalen AM, et al. Comparison of the cancer gene targeting and biochemical selectivities of all targeted kinase inhibitors approved for clinical use. PLoS One 9: e92146, 2014.","DOI":"10.1371\/journal.pone.0092146"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Snyder LS, Hertz MI, Peterson MS, et al. Acute lung injury. Pathogenesis of intraalveolar fibrosis. J Clin Invest 88: 663-673, 1991.","DOI":"10.1172\/JCI115351"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Walsh J, Absher M, Kelley J. Variable expression of platelet-derived growth factor family proteins in acute lung injury. Am J Respir Cell Mol Biol 9: 637-644, 1993.","DOI":"10.1165\/ajrcmb\/9.6.637"},{"key":"16","doi-asserted-by":"crossref","first-page":"e28925","DOI":"10.4161\/onci.28925","volume":"3","author":"A Kreutzman","year":"2014","unstructured":"16. Kreutzman A, Ilander M, Porkka K, Vakkila J, Mustjoki S. Dasatinib promotes Th1-type responses in granzyme B expressing T-cells. Oncoimmunology 3: e28925, 2014.","journal-title":"OncoImmunology","ISSN":"http:\/\/id.crossref.org\/issn\/2162-4011","issn-type":"print"},{"key":"17","unstructured":"17. Schiffer CA, Cortes JE, Hochhaus A, et al. Lymphocytosis after treatment with dasatinib in chronic myeloid leukemia: Effects on response and toxicity. Cancer 122: 1398-1407, 2016."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/18\/59_4714-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T03:44:40Z","timestamp":1600487080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/18\/59_4714-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,15]]},"references-count":17,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4714-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,15]]}}}